...
首页> 外文期刊>Forensic science international >Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.
【24h】

Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.

机译:哌醋甲酯在儿科患者口腔液和汗液中的药代动力学。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Methylphenidate (MPH) is a stimulant medication widely used for treating attention-deficit hyperactivity disorder (ADHD) in children and adolescents. Therapeutic monitoring for this drug is essentially lacking and alternative biological matrices, such as oral fluid and sweat, should be investigated for noninvasive assessment of short- and long-term history of drug use. We report the excretion profile of MHP and its metabolite ritalinic acid (RA) in oral fluid and sweat from a 12-year-old boy treated with the extended release drug formulation. Concentrations of MPH and RA in oral fluid, sweat and plasma were measured by liquid chromatography-mass spectrometry. Oral fluid-to-plasma ratio at each time interval was calculated at the start of the treatment and correlated with salivary pH. Excretion of MPH in sweat patches, collected up to 24h with PharmChek patches was also investigated. MPH and RA were both detected in oral fluid with a pharmacokinetic profile similar to that in plasma. Oral fluid peak concentrations of MPH ranged between 13.5 and 30.9 ng/mL at 3.0 h after drug intake. Oral fluid-to-plasma MPH ratio between 13.1 and 3.2 demonstrated an accumulation of the drug in oral fluid. Conversely, RA was found in oral fluid at peak concentration (23.4-62.9 ng/mL) equivalent to one-tenth of those found in plasma. Concentration profiles of MPH and RA in oral fluid were quite constant during the four weeks of drug administration. In sweat, MPH was detected for the first time at 5h after drug administration (range: 9.3-11.2 ng/patch) up to 24h (range: 29.8-38.7 ng/patch). RA was not detected in the sweat patches during the 24h time of collection. The results suggest that measurement of MPH in oral fluid can be used as a potential alternative to drug monitoring in plasma. Moreover, MPH measurement in sweat patches can be used for noninvasive monitoring of MPH consumption and misuse in situations where detection of recent abuse is of interest.
机译:哌醋甲酯(MPH)是一种刺激性药物,广泛用于治疗儿童和青少年的注意力缺陷多动障碍(ADHD)。基本上没有对该药物的治疗监测,因此应研究替代性生物基质,例如口服液和汗液,以便对药物的短期和长期使用史进行无创评估。我们报告了MHP及其代谢物利他林酸(RA)在口服液和汗液中的排泄情况,该口服液和汗液来自用缓释药物制剂治疗的12岁男孩。用液相色谱-质谱法测定口腔液,汗液和血浆中MPH和RA的浓度。在治疗开始时计算每个时间间隔的口服液与血浆之比,并与唾液pH相关。还研究了用PharmChek斑块收集长达24小时的汗斑中MPH的排泄情况。在口服液中检测到MPH和RA的药代动力学特征与血浆相似。药物摄入后3.0 h,MPH的口服液峰值浓度在13.5至30.9 ng / mL之间。口服液与血浆MPH的比率介于13.1和3.2之间,表明药物在口服液中蓄积。相反,在口腔液中发现的RA峰值浓度(23.4-62.9 ng / mL)等于血浆中的RA的十分之一。在给药的四个星期内,口服液中MPH和RA的浓度分布非常恒定。在出汗中,在给药后5小时(范围:9.3-11.2 ng /贴)至24小时(范围:29.8-38.7 ng /贴)首次检测到MPH。在收集的24小时内未在汗斑中检测到RA。结果表明,口服液中MPH的测量可用作血浆药物监测的潜在替代方法。此外,在最近检测到滥用情况下,汗斑中的MPH测量可用于无创监测MPH消耗和滥用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号